Sameer Ralhan - Chemours President
| CC Stock | USD 17.62 0.85 5.07% |
President
Mr. Sameer Ralhan is Chief Financial Officer, Senior Vice President, Treasurer of the Company. Since joining Chemours in November 2014, Mr. Ralhan held several positions of increasing responsibility in strategy and mergers and acquisitions, finance, and treasury. He served as Vice President, Business Finance and Treasurer from 2018 to 2019 and Vice President, Business Finance and Head of MA from 2016 to 2018. He also served as Treasurer and Head of MA from 2015 to 2016, and Head of MA from 2014 to 2015. Prior to joining Chemours, Mr. Ralhan served as a Managing Director in the Global Natural Resources Group of Goldman Sachs Co. from 2007 to 2014, where he had several assignments advising companies in the chemicals, industrials, and basic materials sectors on MA, portfolio transformations, corporate finance matters, and capital markets transactions. Mr. Ralhan also served as an associate in the investment banking group of Bank of America Securities, LLC from 2004 to 2007 since 2020.
| Age | 50 |
| Tenure | 6 years |
| Address | 1007 Market Street, Wilmington, DE, United States, 19801 |
| Phone | 302 773 1000 |
| Web | https://www.chemours.com |
Chemours Management Efficiency
The company has Return on Asset (ROA) of 0.0249 % which means that for every $100 of assets, it generated a profit of $0.0249. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.938) %, which implies that it produced no returns to current stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.05. The current year's Return On Capital Employed is expected to grow to -0.0008. At present, Chemours' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 3.1 B, whereas Non Currrent Assets Other are forecasted to decline to about 461 M.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Michael Feehan | Ecovyst | 50 | |
| Kim Foley | LyondellBasell Industries NV | 53 | |
| Timothy Bowes | Axalta Coating Systems | 63 | |
| James Seward | LyondellBasell Industries NV | 57 | |
| Timothy Knavish | PPG Industries | ||
| Pedro Salvat | PPG Industries | N/A | |
| Keith Silverman | Ashland Global Holdings | 51 | |
| Richard OLeary | International Flavors Fragrance | 57 | |
| Erica McLaughlin | Cabot | 47 | |
| Paul Whittleston | Ecovyst | 50 | |
| Mary Hall | Quaker Chemical | 62 | |
| Carmen Cain | International Flavors Fragrance | N/A | |
| Jean Gadbois | LyondellBasell Industries NV | N/A | |
| Theodore Clark | H B Fuller | 72 | |
| Traci Jensen | H B Fuller | 57 | |
| Rustom Jilla | International Flavors Fragrance | 58 | |
| Michael McMurray | LyondellBasell Industries NV | 60 | |
| Joseph Matrange | Quaker Chemical | 74 | |
| Melissa Schaeffer | Air Products and | 45 | |
| Matthew Wood | Cabot | N/A | |
| Michael Crocco | Air Products and | 58 | |
Management Performance
| Return On Equity | -0.94 | ||||
| Return On Asset | 0.0249 |
Chemours Leadership Team
Elected by the shareholders, the Chemours' board of directors comprises two types of representatives: Chemours inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemours. The board's role is to monitor Chemours' management team and ensure that shareholders' interests are well served. Chemours' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemours' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dawn Farrell, Independent Chairman of the Board | ||
| Curtis Anastasio, Independent Director | ||
| Jonathan Lock, Senior Vice President and Chief Development Officer | ||
| Amber Wellman, Chief Officer | ||
| David Will, Controller Officer | ||
| Matthew Abbott, Vice President - Digital and Analytics Platforms Leader | ||
| Shane Hostetter, Senior CFO | ||
| David Shelton, Senior Vice President, General Counsel, Secretary | ||
| Damian Gumpel, President Technologies | ||
| Denise Dignam, President - Advanced Performance Materials | ||
| Curtis Crawford, Independent Director | ||
| Aditya Beri, Interim Business | ||
| Mary Cranston, Independent Director | ||
| Bradley Bell, Independent Director | ||
| Matthew Conti, Chief Officer | ||
| Sheryl Telford, Chief Sustainability Officer | ||
| Ron Charles, Senior People | ||
| Erin Kane, Independent Director | ||
| Alisha Bellezza, President - Thermal & Specialized Solutions | ||
| Joseph Martinko, President Solutions | ||
| Susan Kelliher, Senior Vice President – Human Resources and Health Services | ||
| Gerardo Calderon, President Materials | ||
| Michael Foley, President Technologies | ||
| Eugene Snell, President - Titanium Technologies | ||
| Sandra Rogers, Independent Director | ||
| Kurt Bonner, Ma Relations | ||
| Kristine Wellman, General VP | ||
| Sean Keohane, Independent Director | ||
| Sameer Ralhan, Chief Financial Officer, Senior Vice President, Treasurer | ||
| Shane CPA, Senior CFO | ||
| Guillaume Pepy, Independent Director | ||
| Brandon Ontjes, Vice Relations | ||
| Camela Wisel, Chief Accounting Officer, Vice President Controller | ||
| Mark Newman, Chief Operating Officer, Senior Vice President | ||
| Diane Picho, Chief Officer | ||
| Edwin Sparks, President - Chemical Solutions Business, Titanium Technologies | ||
| Erich Parker, Senior Vice President of Corporate Communications and Chief Brand Officer. | ||
| Brian Shay, Interim Officer | ||
| Mark Vergnano, President, Chief Executive Officer, Director | ||
| Richard Brown, Independent Chairman of the Board | ||
| Alvenia Scarborough, Senior Vice President - Corporate Communications and Chief Brand Officer |
Chemours Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemours a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.94 | ||||
| Return On Asset | 0.0249 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 6.42 B | ||||
| Shares Outstanding | 150.09 M | ||||
| Shares Owned By Insiders | 0.55 % | ||||
| Shares Owned By Institutions | 91.40 % | ||||
| Number Of Shares Shorted | 13.96 M | ||||
| Price To Earning | 25.49 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Will Diversified Chemicals sector continue expanding? Could Chemours diversify its offerings? Factors like these will boost the valuation of Chemours. Projected growth potential of Chemours fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Chemours data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.65) | Dividend Share 0.513 | Earnings Share (2.57) | Revenue Per Share | Quarterly Revenue Growth (0.02) |
Understanding Chemours requires distinguishing between market price and book value, where the latter reflects Chemours's accounting equity. The concept of intrinsic value - what Chemours' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Chemours' price substantially above or below its fundamental value.
It's important to distinguish between Chemours' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Chemours should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Chemours' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.